KOSPI records a merchandise sales/sales ratio twice larger than one of KOSDAQ
It was observed the KOSPI listed pharmaceutical companies’ merchandise sales growth rate was much higher than the one of the KOSDAQ. In terms of the merchandise sales ratio to sales, KOSDAQ listed drug companies had a ratio close to 10%, but the KOSPI ones recorded approx. 30%.
According to the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
